ProcureMe https://procuremebs.com Mon, 24 May 2021 18:18:14 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.5 https://procuremebs.com/wp-content/uploads/2021/09/cropped-favicon-procureme-1-32x32.png ProcureMe https://procuremebs.com 32 32 Binske Announces Most Expansive Canadian Distribution Deal In History With Canadian Innovator CannaPiece https://procuremebs.com/binske-distribution-deal-cannapiece/ Thu, 22 Apr 2021 17:06:38 +0000 https://site.cannapiecegroup.com/?p=248 DENVER, Feb. 18, 2021 /PRNewswire/ — Praetorian Global, the parent company of the award-winning cannabis brand Binske, has signed a historic licensing deal with Canadian licensed cannabis producer CannaPiece.

In a bit of a paradox, 2020 may well go down as the most important year in the history of legal cannabis, which started with most legal U.S. state markets (either medical or recreational) designating cannabis as an “essential” business at the start of the pandemic. From there, the overall marketplace continued to gather additional momentum and go on to set sales records in almost every single legal marketplace.

“The strong market performance taking place during the worst pandemic in modern history signifies a shift in the collective zeitgeist of consumers towards cannabis. Cannabis usage has become more and more socially acceptable which is primarily being driven by legal cannabis becoming increasingly easy to access by a greater percentage of the North American population”, said Praetorian Global’s Founder, Chairman and CEO Jacob Pasternack.

Binske now has access to over 89.4 million consumers in North America, continuing its trajectory as one of the fastest growing and widely distributed cannabis brands in the world. This marks the 16th licensing deal that Praetorian Global is party to and is particularly notable due to the depth of the Binske product suite. While most U.S. brands crossing over into the Canadian market are single product brands, Binske has over 100 SKU’s in its portfolio centered around the primary product categories of flower, vapes, extracts and edibles.

The Canadian cannabis market, fueled by a population of 37 million people, is projected to generate over $7 billion dollars annually by 2026. The landmark agreement between Praetorian and CannaPiece has an estimated retail value of over $50M (CAD). The companies plan to roll out the first tranche of products in Q2 2021 and have the full suite of award-winning products available to Canadian consumers by the summer of 2021.

“Binske focuses on earning and most importantly retaining consumer trust by enhancing the cannabis experience through strict product efficacy, constant innovation and overall product quality. We have put significant time and resources into developing a nucleus of consumer patronage in the U.S. markets and will now strategically take that same level of dedication towards consumer experience to the Canadian market,” continued Jacob Pasternack.

“It has been an exciting journey working with the Binske team to bring and introduce their brand experience to the Canadian market and we are very eager to see their products on the shelves,” said Eric Akbar, President for CannaPiece

“Introduction of established US brands is the natural progression of market maturity in Canada and CannaPiece Corp., as a contract manufacturer, is here to pave the path forward,” he continued.

“CannaPiece has a dynamic and sophisticated executive team, with state-of-the-art facilities, and understands as well as appreciates the attention-to-detail that we have put into crafting Binske. Our ideal licensing partners understand the brand’s ethos, and work diligently with us to bring the full portfolio of products and brand experience to each and every new territory,” says Alex Pasternack, executive vice president at Binske. “Partner-selection is paramount for us, so naturally we feel incredibly excited to have CannaPiece license and produce our suite of products in Canada.”

About Praetorian Global

Founded by Chairman and CEO Jacob Pasternack in 2015, Denver-based Praetorian Global, holds interests in THC and CBD-related brands throughout the U.S. Privately held Praetorian Global is the parent company for Binske, (the “e” is silent as in “smoke”). Because of its distinct intellectual property model and best-in-class product lines, Binske is party to 16 licensing deals in the U.S. states and Canada, making Binske the most widely distributed cannabis brand in North America. Lauded for its proprietary strains, craft ingredients, and best-in-class packaging, Binske products have earned multiple awards, including Leafly’s Best Edibles, Best Concentrates and Best Overall Company. Binske has been covered in publications such as Forbes, Yahoo Finance, Benzinga, Marjiuana Business Magazine, Bloomberg, Ad Weekly, The New Times, and Cheddar TV. Binske is a registered trademark of Praetorian Global.

ABOUT CANNAPIECE CORP.

Headquartered in Pickering, Ontario, CannaPiece Corp. is a wholly-owned subsidiary of CannaPiece Group Inc., a Canadian based, vertically integrated cannabis company. CannaPiece Corp. is a contract manufacturer of cannabis and hemp products and provides the industry with services and products to cover gaps in the supply chain. CannaPiece offers a complete selection of high-quality services ranging from R&D, product development, third-party processing, packaging, large-scale extraction, production of edibles, topicals and concentrates as well as white-labeled products to the Canadian market.

Source: PR Newswire

]]>
IGNITE International Brands, Ltd. Enters Manufacturing Agreement With CannaPiece Corp. https://procuremebs.com/ignite-brands-agreement-cannapiece-corp/ Wed, 21 Apr 2021 17:08:58 +0000 https://site.cannapiecegroup.com/?p=252 VAUGHAN, Ontario, Oct. 26, 2020 (GLOBE NEWSWIRE) — IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”), a global consumer packaged goods brand, is pleased to announce that it has broadened its manufacturing capabilities by signing a contract manufacturing agreement with CannaPiece Corp. (“CannaPiece”), a leading contract manufacturer of cannabis and hemp. CannaPiece operates a 50,000 square foot state-of-the-art licensed manufacturing and processing facility, with ability to expand its operations to 150,000 square feet. The operation includes R&D, Product Development, Third-Party Processing, Packaging, Large-Scale Extraction, Production of Edibles, Topicals and Concentrates with the ability to provide IGNITE Branded products to domestic markets.

“Canada has shown to be a burgeoning market for IGNITE. Collaboration with CannaPiece is a strategic move that will position IGNITE to maximize its potential in the Canadian cannabis market,” said Gene Bernaudo, Global Head of Cannabis at IGNITE. “Curating premium craft cannabis and delivering consistent products has gained the loyalty of consumers and has been essential to generating brand awareness as IGNITE continues to scale the country. Demand for IGNITE products has grown since launch and the team at CannaPiece will be instrumental to IGNITE’s ability to meet demand and deliver uber-premium cannabis products.”

“CannaPiece is excited to be the manufacturing body for IGNITE, and we look forward to leveraging our manufacturing expertise, technology and high-end equipment to offer sustainable high quality cannabis and hemp products to the Canadian market,” said Afshin Souzankar, Chief Operating Officer at CannaPiece.

About IGNITE

IGNITE is a global consumer brand, operating in the premium product segment of the market. Founded by Dan Bilzerian, the Company’s ‘quality‐first’ approach is fundamental to the brand and its products. Originally operating in the cannabis and hemp‐derived cannabidiol (CBD) wellness space, IGNITE was able to establish its brand awareness. IGNITE product categories now include a full line of CBD oil tinctures, CBD topicals, CBD pet products and CBD vape devices, nicotine and synthetic nicotine vape products, a line of premium performance drinks, named Z‐RO as well as a gluten‐free, seven‐time distilled vodka, and apparel produced by various partners and sold through select distributors, brick and mortar retailers, and online through the Company’s website, ignite.co. The IGNITE THC product line, which was launched subsequent to the CBD product line, incorporates quality, locally sourced, cannabis products.

Shares of IGNITE are listed on the CSE under the symbol “BILZ” and quoted in the United States on the OTCQX under the symbol “BILZF”.

Further information on IGNITE can be found on the Company’s website at ignite.co.

For further information, please contact:

ABOUT CANNAPIECE CORP.

Headquartered in Pickering, Ontario, CannaPiece Corp. is a wholly-owned subsidiary of CannaPiece Group Inc., a Canadian based, vertically integrated cannabis company. CannaPiece Corp. is a contract manufacturer of cannabis and hemp products and provides the industry with services and products to cover gaps in the supply chain. CannaPiece offers a complete selection of high-quality services ranging from R&D, product development, third-party processing, packaging, large-scale extraction, production of edibles, topicals and concentrates as well as white-labeled products to the Canadian market.

CAUTIONARY STATEMENT REGARDING FORWARD‐LOOKING INFORMATION

This news release includes certain “forward‐looking statements” under applicable Canadian securities legislation. Forward‐looking statements include, but are not limited to, the success of the arrangements with CannaPiece, the ability of IGNITE to distribute its products in Canada successfully and the ability to have a successful market strategy in Canada. Forward‐looking statements are necessarily based upon several estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward‐looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the effects and impacts of the coronavirus disease (COVID‐19) pandemic, the extent and duration of which are uncertain at this time on IGNITE’s business and general economic and business conditions and markets; the ability of IGNITE to give effect to its business plan; reliance on the “IGNITE” brand which may not prove to be as successful as contemplated; the ability to and risks associated with unlocking future licensing opportunities with the “IGNITE” brand, and the ability of IGNITE to capture significant market share. There can be no assurance that any of the forward‐looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward‐looking statements. The Company disclaims any intention or obligation to update or revise any forward‐looking statements, whether because of new information, future events or otherwise, except as required by law.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

]]>
6Pak Creates Strategic Alliance with CannaPiece Corp https://procuremebs.com/6pak-creates-strategic-alliance-with-cannapiece-corp/ Tue, 20 Apr 2021 17:09:01 +0000 https://site.cannapiecegroup.com/?p=253 ATG Pharma’s packing arm joins forces with one of Ontario’s most extensive extraction facility to supplyhigh-demand products currently in shortage

TORONTO, Dec. 14, 2020 /CNW/ – 6PAK Solutions Inc. (“6PAK“), the packing arm of ATG Pharma Inc., today announced a three-year Strategic Alliance with CannaPiece Corp. (“CannaPiece“), one of Ontario’s most sophisticated processors and manufacturers.

Through the formation of this alliance, CannaPiece Corp will be equipped to increase capacity, expertise and co-packing abilities – allowing the company to manufacture high demand Cannabis 2.0 and 3.0 products on behalf of their contract clients.

“This alliance with CannaPiece is a pivotal moment for 6Pak as we can now have the ability to take on co-packing contracts for our clients under a Health Canada License,” said Chris Shar, Co-Founder of 6Pak Solutions. “With Cannabis 3.0 on the rise, we want to continue to be a trusted partner to our clients by helping them bring new and innovative products to market faster and more efficiently. Through CannaPiece, we will be able to do so.”

Equipment supplied by 6Pak will operate out of CannaPiece’s 50,000 square foot, state-of-the-art Health Canada licensed facility in Pickering, Ontario. The facility currently offers a variety of services such as large-scale extraction, third party processing and production of edibles, topicals and concentrates. Alongside filling and packaging equipment, 6Pak will also bring their industry expertise in staffing and continuous enhancement and maintenance.

“Leveraging off ATG’s years of industry experience, 6Pak has had a front-row seat to the market evolution. Their trusted expertise and cutting-edge equipment make them the most suitable partner for CannaPiece as we seek to meet growing volumes and timelines,” said Eric Akbar, Vice President Operations, CannaPiece Corp. “The true beneficiaries of this alliance will be consumers as we position ourselves to get new innovative products to market faster, and free up company cash flow for the rapidly expanding market.”

CannaPiece’s trusted extraction services, custom formulations and delivery systems paired with 6Pak’s ready on time filling packaging solutions offers companies a unique, full turn-key solution to expand current product lines or develop new ones – creating the opportunity to gain market share in the rapidly growing space.

About 6Pak Solutions

6Pak Solutions is a contract packing arm of ATG Pharma Inc., a leader in regulatory compliant filling and packaging equipment for the Cannabis Industry. With a front-row seat to the market evolution, they have been experts in the cannabis space for over five years, working with the majority of Licensed Oil Producers in Canada. 6Pak Solutions offers more flexible contract packaging solutions, strategically partnering and operating out of Licensed Facilities.

About CannaPiece Corp.

Located in Pickering, Ontario, CannaPiece Corp is the processing and manufacturing arm of CannaPiece Group. With one of the most extensive extraction facilities in Ontario and state-of-the-art processing and manufacturing. The Pickering facility provides complete solutions for licensed producers seeking top of the line services such as research and product development, processing, large-scale extraction, tolling, and packaging services.

Source: Newswire

]]>
CannaPiece Statement on COVID-19 https://procuremebs.com/cannapiece-statement-covid19/ Mon, 19 Apr 2021 17:10:00 +0000 https://site.cannapiecegroup.com/?p=254 Dear CannaPiece Team, Friends and Family,

Nothing is more important to us at CannaPiece than the health and safety of our employees, customers, partners and their families.  Since it began, we have been closely monitoring the spread of COVID-19 (novel Coronavirus) and early on made major changes geared towards protecting all of those who work and interact with our company and within our facilities.  We are following the guidance and directives of our government and health experts along with the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).

In all cases possible, our staff is working from home and maintaining social distancing, leaving only for essentials (groceries, medication, etc.).  As a manufacturer that has been deemed an essential service, we do have employees that are required to continue to work from our facilities.  Within our offices and facilities we have enhanced our already comprehensive cleaning and sanitization procedures with instructions to increase the frequency of cleaning commonly touched surfaces, including bathrooms, touchscreens, door handles, equipment and security pin pads.  We have also implemented high level screening (including mandatory detailed travel and health questions and the taking of temperature each day) of any person entering our premises.  Additionally we have coordinated split shift schedules for staff to further protect their health and ensure the continuity of our business and services.

At CannaPiece, we understand the vital role that our people play and will continue to take the necessary precautions to help prevent the spread of COVID-19.  We look forward to coming out of these difficult times together as a team and end up as a stronger and closer family.

]]>
CannaPiece Corp. Receives Processing and Sales Licence from Health Canada https://procuremebs.com/cannapiece-corp-health-canada-licence/ Sun, 18 Apr 2021 17:10:00 +0000 https://site.cannapiecegroup.com/?p=262 The licence authorizes CannaPiece Corp. to immediately begin the processing and manufacturing of cannabis and hemp products at their state-of-the-art, 50,000 sq. ft. facility located in Pickering, Ontario .

MARKHAM, ON , March 3, 2020 /CNW/ – CannaPiece Corp. (“CannaPiece” or the “company“) is pleased to announce it has been granted its Standard Processing and Sale for Medical Purposes Licence (the “licence“) from Health Canada on February 28, 2020 .

“We have been waiting anxiously for our licence and are ready to play a significant role in the newly established legal cannabis 2.0 market,” said Ray Ahmad Rasouli , CEO of CannaPiece Corp. “The licence marks only the beginning for our company, and we are excited by the opportunity to work with licensed producers whose visions align with ours — to deliver high calibre cannabis products to consumers.”

The Pickering facility will provide complete solutions for licensed producers seeking top of the line services such as R&D, product development, third-party processing, flower packaging, large-scale extraction, production of edibles, topicals and concentrates as well as white-labeled products to both domestic and international markets.

CannaPiece Corp. is motivated to deliver and preserve the quality and consistency of its cannabis processing for the clients who entrust in their services. The processing and manufacturing facility is equipped with the highest level of security and exceptional operating practices that allows the facility to become a fully EU-GMP certified facility in Canada .

About CannaPiece Corp.

Headquartered in Pickering, Ontario , CannaPiece Corp is a wholly owned subsidiary of CannaPiece Group; a Canadian based, vertically integrated cannabis company. CannaPiece Corp is a contract manufacturer in cannabis and hemp seeking to establish new standards in providing the industry with services and products to cover the gaps in the supply chain. They will offer a complete selection of high-quality services ranging from R&D, product development, third-party processing, packaging, large-scale extraction, production of edibles, topicals and concentrates as well as white-labeled products to both domestic and international markets.

For more information, please visit www.CannaPieceCorp.com.

This Release may contain forward-looking statements which reflect management’s expectations regarding the Company’s objectives, plans, goals, strategies, future growth, financial condition, results of operations, cash flows, performance, business prospects and opportunities. All statements other than statements of historical facts included in this website, including statements regarding the Company’s objectives, plans, goals, strategies, future growth, financial condition, results of operations, cash flows, performance, business prospects and opportunities, may constitute forward-looking information. Expressions such as “anticipates”, “expects”, “believes”, “estimates”, “could”, “intends”, “may”, “plans”, “predicts”, “projects”, “will”, “would” and other similar expressions, or the negative of these terms, are generally indicative of forward-looking statements.

These statements are based on CannaPiece Group management’s reasonable assumptions and beliefs considering the information available to them at the time such statements are made. The forward-looking information contained in this Release is presented for the purpose of assisting the Company’s security holders in understanding its financial position and results of operation as at and for the periods ended on the dates presented and the Company’s strategic priorities and objectives, and may not be appropriate for other purposes. By its very nature, the information requires the Company to make assumptions and is subject to inherent risks and uncertainties which give rise to the possibility that the Company’s predictions, forecasts, expectations or conclusions will not prove to be accurate, that the Company’s assumptions may not be correct and that the Company’s objectives, strategic goals and priorities will not be achieved. Although the Company believes that the predictions, forecasts, expectations or conclusions reflected in the forward-looking information are reasonable, it can give no assurance that such matters will prove to have been correct. Such forward-looking information is not fact but only reflects management’s estimates and expectations. These forward-looking statements are subject to uncertainties and other factors that could cause actual results to differ materially from such statements.  These factors include but are not limited to: changes in general industry, market and economic conditions, competition from existing and new competitors, energy prices, supply issues, inventory management, changes in demand due to seasonality of the business, interest rates, changes in laws and regulations, operating efficiencies and cost saving initiatives.

Source: Yahoo Finance

]]>